Dental Anesthesia Companies
Dental anesthesia companies play a critical role in providing products and solutions to ensure patients' comfort during various dental procedures. These companies offer a range of dental anesthetics and related products.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Disclaimer: List of key companies in no particular orderLatest Dental anesthesia Companies Update
-
May 2023: The leading sterile injectable contract manufacturing and development organization (CDMO) in Ontario, Novocol Pharma, has entered into a long-term agreement with Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, to perform aseptic fill-finish, labeling, and packaging of mRNA respiratory vaccines anticipated to be produced in Canada. The last stage of the production cycle, known as fill-finish sterile manufacturing, entails putting the vaccine medication product into vials and preparing it for use. The deal with Novocol Pharma will increase the fill-finish capacity of vaccines produced at Moderna's mRNA facility in Laval. Subject to planning and regulatory permissions, the facility is anticipated to open for business by the end of 2024.
-
Aug 2023: For a purchase price of $70 million, subject to closing and other changes, 3M stated that it had finalized the sale of some assets from its dentistry local anesthetic portfolio, based in Germany, to Pierrel S.p.A. ("Pierrel"), a worldwide provider of services for the pharmaceutical sector. These local anesthetic items, which are mostly sold in Europe and Asia, comprise related syringe and needle products as well as goods sold under the trademarks UbistesinTM, XylestesinTM, and MepivastesinTM. These were previously a component of 3M's Oral Care Solutions Division's dental materials business. 3M decided to discontinue these products as part of its continuing strategic portfolio management and to give priority to initiatives that make use of the fundamental oral care technologies of its Health Care business.
List of Dental anesthesia Key companies in the market
- Dentsply Sirona (US)
- Septodont, Inc. (France)
- AstraZeneca (UK)
- Primex Pharmaceuticals (Europe)
- 3m (US)
- Centrix, Inc (US)
- Cetylite, Inc (US)
- Crosstex International, Inc. (US)
- Dmg America (US)
- Henry Schein, Inc. (US)
- Patterson Companies, Inc. (US)
- Pierrel SPA (Italy)
Dental Anesthesia Market Highlights:
Dental Anesthesia Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
